Has Miguel Orellana, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,495 in general payments to Miguel Orellana, MD across 209 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Miguel Orellana, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Miguel Orellana, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Miguel Orellana, MD

Hospitalist · El Paso, TXNPI 1588607071

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Abbott at 25.4% of the total. Reporting peaked in 2021 at $1,555 and has fallen 80.2% since, to $308 in 2025. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,495in general payments, 2019–2025

Across 209 payments — averaging $26.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$1K
E.r. Squibb & Sons, L.L.C.$610
AstraZeneca$553
Novartis$538
Johnson & Johnson$498
Pfizer$330
plus $2K from 13 others

What the payments were for

Food & beverage$5,41599%
Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	22	$1,397
E.r. Squibb & Sons, L.L.C.	54	$610
AstraZeneca(2 entities)	21	$553
Novartis	30	$538
Johnson & Johnson	19	$498
Pfizer	17	$330
Boston Scientific	9	$280
Boehringer Ingelheim	2	$195
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	7	$171
Astellas Pharma US Inc	4	$155
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$150
Vifor Pharma, Inc.	1	$118
Angiodynamics, Inc.	3	$109
Inspire Medical Systems, Inc.	1	$97
AbbVie(2 entities)	4	$85
Urgo Medical North America, LLC	1	$73
Smith+Nephew	4	$63
Impulse Dynamics (USA) Inc.	1	$51
Solventum Corporation	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,495 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas →

Medicare billing

Part B allowed, 2024

$7,986

Medicare patients

Services billed

134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	39	$492
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$233
Ampicillin Trihydrate	13	$210
Clindamycin Hcl	13	$209
Levofloxacin	47	$183
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	15	$116
Pantoprazole Sodium	23	$100
Atorvastatin Calcium	13	$63
Furosemide	15	$39
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$37

Paid to pharmacies, not to this prescriber.

Other hospitalist in El Paso

Paul MathewEl Paso$18K
Adam GomezEl Paso$4K
Kenechukwu EnekebeCorpus Christi$311K
Ryan NealHouston$154K
Sarah SmileyAustin$90K
Mubeen CheemaSan Antonio$50K
Ahmad BaroutHouston$44K
Tarek HammadSan Antonio$42K
Hendre FichardtSan Antonio$36K
Sadie Trammell VelasquezSan Antonio$36K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →